Article Details
Retrieved on: 2021-04-14 16:07:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
That is at the top end of the range of reductions achieved with monoclonal antibodies targeting SARS-CoV-2 that have been granted EUAs by the FDA ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here